{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T16:24:33Z","timestamp":1764433473186},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,5]]},"DOI":"10.7759\/cureus.27702","type":"journal-article","created":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T14:49:25Z","timestamp":1659710965000},"source":"Crossref","is-referenced-by-count":2,"title":["Antiphospholipid Syndrome Secondary to Lupus Anticoagulant: Case Report for Clinical Anticoagulation Determination"],"prefix":"10.7759","author":[{"given":"Constantino G","family":"Lambroussis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald","family":"Foster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Antiphospholipid Syndrome Foundation of America, Inc. Antiphospholipid Antibody Syndrome. (2022). Accessed. May 6, 2022: https:\/\/apsfa.org\/docs\/APSBookletAPSFA0910.pdf."},{"key":"ref2","unstructured":"Antiphospholipid syndrome. (2022). Accessed. May 6, 2022: https:\/\/www.mayoclinic.org\/diseases-conditions\/antiphospholipid-syndrome\/symptoms-causes\/syc-20355831."},{"key":"ref3","unstructured":"Antiphospholipid antibody syndrome. (2022). Accessed. May 17, 2022: https:\/\/www.nhlbi.nih.gov\/health-topics\/antiphospholipid-antibody-syndrome."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1590\/1806-9282.63.11.994","article-title":"Update on antiphospholipid antibody syndrome","volume":"63","author":"Lopes MR","year":"2017","unstructured":"Lopes MR, Danowski A, Funke A, R\u00eago J, Levy R, Andrade DC. Update on antiphospholipid antibody syndrome. Rev Assoc Med Bras (1992). 2017, 63:994-9. 10.1590\/1806-9282.63.11.994","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"ref5","unstructured":"Top 10 series. Catastrophic antiphospholipid syndrome. Hospital for special surgery. (2022). Accessed: May 17, 2022: https:\/\/www.hss.edu\/conditions_top-ten-points-for-patients-catastrophic-antiphospholipid-syndrome.asp."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/ncprheum0069","article-title":"Catastrophic antiphospholipid syndrome","volume":"2","author":"Merrill JT","year":"2006","unstructured":"Merrill JT, Asherson RA. Catastrophic antiphospholipid syndrome. Nat Clin Pract Rheumatol. 2006, 2:81-9. 10.1038\/ncprheum0069","journal-title":"Nat Clin Pract Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X13502919","article-title":"Catastrophic antiphospholipid syndrome: how to diagnose a rare but highly fatal disease","volume":"5","author":"Aguiar CL","year":"2013","unstructured":"Aguiar CL, Erkan D. Catastrophic antiphospholipid syndrome: how to diagnose a rare but highly fatal disease. Ther Adv Musculoskelet Dis. 2013, 5:305-14. 10.1177\/1759720X13502919","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-12-129627","article-title":"How we diagnose the antiphospholipid syndrome","volume":"113","author":"Giannakopoulos B","year":"2009","unstructured":"Giannakopoulos B, Passam F, Ioannou Y, Krilis SA. How we diagnose the antiphospholipid syndrome. Blood. 2009, 113:985-94. 10.1182\/blood-2007-12-129627","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2012.00150","article-title":"Antiphospholipid-related chorea","volume":"3","author":"Peluso S","year":"2012","unstructured":"Peluso S, Antenora A, De Rosa A, Roca A, Maddaluno G, Brescia Morra V, De Michele G. Antiphospholipid-related chorea. Front Neurol. 2012, 3:150. 10.3389\/fneur.2012.00150","journal-title":"Front Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1590\/1677-5449.011416","article-title":"A import\u00e2ncia de reconhecer a s\u00edndrome antifosfol\u00edpide na medicina vascular","volume":"16","author":"Funke A","year":"2017","unstructured":"Funke A, Danowski A, de Andrade DC, R\u00eago J, Levy RA. A import\u00e2ncia de reconhecer a s\u00edndrome antifosfol\u00edpide na medicina vascular. J Vasc Bras. 2017, 16:140-9. 10.1590\/1677-5449.011416","journal-title":"J Vasc Bras"},{"key":"ref11","article-title":"Cognitive dysfunction in antiphospholipid antibody (aPL)-negative systemic lupus erythematosus (SLE) versus aPL-positive non-SLE patients","volume":"32","author":"Kozora E","year":"2014","unstructured":"Kozora E, Erkan D, Zhang L, Zimmerman R, Ramon G, Ulug AM, Lockshin MD. Cognitive dysfunction in antiphospholipid antibody (aPL)-negative systemic lupus erythematosus (SLE) versus aPL-positive non-SLE patients. Clin Exp Rheumatol. 2014, 32:34-40.","journal-title":"Clin Exp Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.26022","article-title":"Neurological and neuropsychiatric manifestations of antiphospholipid-antibody syndrome (APS)","volume":"14","author":"Asif S","year":"2022","unstructured":"Asif S, Bali A, Dang AK, Gonzalez DA, Kumar R. Neurological and neuropsychiatric manifestations of antiphospholipid-antibody syndrome (APS). Cureus. 2022, 14:e26022. 10.7759\/cureus.26022","journal-title":"Cureus"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2013.1.675","article-title":"Antiphospholipid syndrome","volume":"2013","author":"Lim W","year":"2013","unstructured":"Lim W. Antiphospholipid syndrome. Hematology Am Soc Hematol Educ Program. 2013, 2013:675-80. 10.1182\/asheducation-2013.1.675","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref14","unstructured":"National Institutes of Health National Library of Medicine. Antiphospholipid syndrome. (2022). Accessed. May 26, 2022: https:\/\/medlineplus.gov\/genetics\/condition\/antiphospholipid-syndrome\/."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/106598-antiphospholipid-syndrome-secondary-to-lupus-anticoagulant-case-report-for-clinical-anticoagulation-determination","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:37:00Z","timestamp":1707507420000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/106598-antiphospholipid-syndrome-secondary-to-lupus-anticoagulant-case-report-for-clinical-anticoagulation-determination"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,5]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.27702","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,5]]}}}